• Poster

Cost-effectiveness of Delayed-Release Dimethyl Fumarate Compared With Glatiramer Acetate and Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis

Citation

Mauskopf, J., Fay, M., Iyer, R., Sarda, S., & Livingston, T. (2014, June). Cost-effectiveness of Delayed-Release Dimethyl Fumarate Compared With Glatiramer Acetate and Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis. Presented at ISPOR 19th Annual International Meeting, .

Abstract